Literature DB >> 15898843

Ulcerative cutaneous mycobacteriosis due to Mycobacterium ulcerans: report of two Mexican cases.

Josefa Novales-Santa Coloma1, Gisela Navarrete-Franco, Pedro Iribe, Larissa Dorina López-Cepeda.   

Abstract

We report two patients from Central Mexico, with ulcerated cutaneous lesions containing acid-fast bacilli (AFB) and ultimately diagnosed as Mycobacterium ulcerans disease. The first patient had a long history (11 years) of disease involving multiple lesions of both upper and lower extremities. Histopathological changes included necrosis of the subcutaneous tissue with large numbers of extracellular AFB. Cultures at 32 degrees C were "positive for mycobacteria," but were not further identified. The polymerase chain reaction for M. ulcerans performed on skin bopsies was positive. The lesions improved after treatment with rifampin and isoniazid (INH) for one month, followed by ethambutol and streptomycin. The second case followed trauma to the right hand, which spread over 2 years to the right upper extremity, the back, and both legs, with a loss of digits and metacarpal bones of the right hand. The histopathological findings were similar to the first case, including presence of AFB. PCR for M. ulcerans on extracts of skin biopsies was positive. Rifampin, INH, pyrazinamide, and levofloxacin resulted in marked improvement of the ulcer; ethambutol and streptomycin were later used, also. We report these cases because they are rare (approximately 6 previous cases were reported from Mexico), and both are unusually disseminated. They are significant in alerting the medical community to M. ulcerans infection, which is still active in Mexico, and the treatment used has not been reported previously.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15898843     DOI: 10.1489/1544-581X(2005)73[5:UCMDTM]2.0.CO;2

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  8 in total

1.  Combining PCR with microscopy to reduce costs of laboratory diagnosis of Buruli ulcer.

Authors:  Dorothy Yeboah-Manu; Adwoa Asante-Poku; Kobina Asan-Ampah; Emelia Danso Edwin Ampadu; Gerd Pluschke
Journal:  Am J Trop Med Hyg       Date:  2011-11       Impact factor: 2.345

2.  Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.

Authors:  Alexandra G Fraga; Andrea Cruz; Teresa G Martins; Egídio Torrado; Margarida Saraiva; Daniela R Pereira; Wayne M Meyers; Françoise Portaels; Manuel T Silva; António G Castro; Jorge Pedrosa
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Evidence for an intramacrophage growth phase of Mycobacterium ulcerans.

Authors:  Egídio Torrado; Alexandra G Fraga; António G Castro; Pieter Stragier; Wayne M Meyers; Françoise Portaels; Manuel T Silva; Jorge Pedrosa
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

Review 4.  Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.

Authors:  Dezemon Zingue; Amar Bouam; Roger B D Tian; Michel Drancourt
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

5.  A quick and cost effective method for the diagnosis of Mycobacterium ulcerans infection.

Authors:  Dziedzom K de Souza; Charles Quaye; Lydia Mosi; Phyllis Addo; Daniel A Boakye
Journal:  BMC Infect Dis       Date:  2012-01-18       Impact factor: 3.090

Review 6.  Clinical and Laboratory Diagnosis of Buruli Ulcer Disease: A Systematic Review.

Authors:  Samuel A Sakyi; Samuel Y Aboagye; Isaac Darko Otchere; Dorothy Yeboah-Manu
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-06-20       Impact factor: 2.471

7.  RNA Aptamer That Specifically Binds to Mycolactone and Serves as a Diagnostic Tool for Diagnosis of Buruli Ulcer.

Authors:  Samuel A Sakyi; Samuel Yaw Aboagye; Isaac Darko Otchere; Albert M Liao; Thomas G Caltagirone; Dorothy Yeboah-Manu
Journal:  PLoS Negl Trop Dis       Date:  2016-10-24

8.  Recombinant Antibodies against Mycolactone.

Authors:  Leslie Naranjo; Fortunato Ferrara; Nicolas Blanchard; Caroline Demangel; Sara D'Angelo; M Frank Erasmus; Andre A Teixera; Andrew R M Bradbury
Journal:  Toxins (Basel)       Date:  2019-06-17       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.